Search Result "2D QSAR"
A Review on Principles, Theory and Practices of 2D-QSAR
Journal: Current Drug Metabolism
Volume: 15 Issue: 4 Year: 2014 Page: 346-379
Author(s): Kunal Roy,Rudra Narayan Das
2D-QSAR: The Mathematics behind the Drug Design Methodology
Ebook: New Developments in Medicinal Chemistry
Volume: 1 Year: 2010
Author(s): Ana Conejo-Garcia,Miguel A. Gallo,Antonio Espinosa,Joaquin Maria Campos
Doi: 10.2174/978160805127411001010079
Identifying the Structural Features of Diphenyl Ether Analogues for InhA Inhibition: A 2D and 3D QSAR Based Study
Journal: Letters in Drug Design & Discovery
Volume: 17 Issue: 1 Year: 2020 Page: 31-47
Author(s): Ashutosh Prasad Tiwari,Varadaraj Bhat Giliyar,Gurypur Gautham Shenoy,Vandana Kalwaja Eshwara
â2D, 3D QSAR and Pharmacophore Identification of Thieno[3,2-d]pyrimidinesas Cholesterol inhibitorsâ
Journal: Current Indian Science
Volume: 2 Issue: 1 Year: 2024 Page: 1-13
Author(s): Rakesh D. Amrutkar,Kishor S Jain
2D- and 3D-QSAR Modeling of Imidazole-Based Glutaminyl Cyclase Inhibitors
Journal: Current Computer-Aided Drug Design
Volume: 16 Issue: 6 Year: 2020 Page: 682-697
Author(s): Omar Husham Ahmed Al-Attraqchi,Katharigatta N. Venugopala
2D- and 3D-QSAR Studies of Flavonoids, Biflavones and Chalcones: Antiviral, Antibacterial, Antifungal, and Antimycobacterial Activities
Journal: Anti-Infective Agents
Volume: 10 Issue: 1 Year: 2012 Page: 41-54
Author(s): Andrew G. Mercader, Alicia B. Pomilio
Molecular Docking, 3D-QSAR, Fingerprint-Based 2D-QSAR, Analysis of Pyrimidine, and Analogs of ALK (Anaplastic Lymphoma Kinase) Inhibitors as an Anticancer Agent
Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 5 Year: 2021 Page: 509-521
Author(s): Vivek Yadav,Rajiv Kumar Tonk,Ramchander Khatri
QSAR in the Pharmaceutical Research Setting: QSAR Models for Broad, Large Problems
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 6 Year: 2010 Page: 619-637
Author(s): D.G. Sprous, R.K. Palmer, J. T. Swanson, M. Lawless
2D, 3D, G-QSAR and Docking Studies of Thiazolyl-pyrazoline Analogues as Potent (Epidermal Growth Factor Receptor-tyrosine Kinase) EGFR-TK Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 11 Year: 2017 Page: 1228-1238
Author(s): Ghodgaonkar Sunayana,Bhandari Shashikant,Waghulde Sandeep
2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA
Journal: Current Computer-Aided Drug Design
Volume: 11 Issue: 4 Year: 2015 Page: 292-303
Author(s): Eslam Pourbasheer,Reza Aalizadeh,Hamid Mohammad Shiri,Alireza Banaei,Mohammad Reza Ganjali